Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial
Titel:
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial
Auteur:
Nakagawa, Kazuhiko Garon, Edward B Seto, Takashi Nishio, Makoto Ponce Aix, Santiago Paz-Ares, Luis Chiu, Chao-Hua Park, Keunchil Novello, Silvia Nadal, Ernest Imamura, Fumio Yoh, Kiyotaka Shih, Jin-Yuan Au, Kwok Hung Moro-Sibilot, Denis Enatsu, Sotaro Zimmermann, Annamaria Frimodt-Moller, Bente Visseren-Grul, Carla Reck, Martin